How does COVID-19 have an effect on sexual and bladder features in males?

The coronavirus illness 2019 (COVID-19) pandemic has adversely impacted the lives of tens of millions of individuals all through the world. To this point, COVID-19 has claimed the lives of over 6.4 million globally.

Many have recommended that folks with persistent urinary issues are extra inclined to extreme COVID-19. Moreover, males with comorbidities like benign prostatic hyperplasia (BPH), prostate most cancers, erectile dysfunction (ED), and infertility are additionally thought of to be extra weak to COVID-19.

Study: Impact of COVID-19 on male urogenital health: success of vaccines. Image Credit: Studio Romantic /

Examine: Impact of COVID-19 on male urogenital health: success of vaccines. Picture Credit score: Studio Romantic /


The extreme acute respiratory syndrome coronavirus 2 (SARS-CoV-2) makes use of its spike (S) protein to bind to the angiotensin-converting enzyme 2 (ACE2) receptor situated on the floor of host cells. The priming of the S protein is carried out by transmembrane serine protease 2 (TMPRSS2), which divides the S protein on the S1/S2 web site.

The expression of ACE2 in testicular tissues can enhance their danger of being focused by SARS-CoV-2. Moreover, the affiliation of androgen receptor signaling with COVID-19 severity has additionally supplied proof as to why males are sometimes at a higher danger of extreme illness.

A current Drug Discovery Today journal examine discusses the impression of COVID-19 on the urogenital well being of males.

Prostate most cancers

Prostate most cancers is without doubt one of the most prevalent forms of most cancers and is accountable for most cancer-related deaths in males globally. Excessive ranges of TMPRSS2 and ACE2 expression have been noticed within the prostate tissue.

Earlier research have reported that downregulation of ACE2 expression, together with a rise in ACE2 exercise, is related to prostate carcinogenesis. The overexpression of TMPRSS2 in prostate most cancers additional suggests a hyperlink between prostate most cancers and SARS-CoV-2.

Researchers have postulated that TMPRSS2 and anti-androgen inhibitors can probably be used as efficient remedies for prostate most cancers sufferers who’re affected by COVID-19. Thus, the potential profit in altering TMPRSS2 expression ranges can help within the growth new therapies for treating COVID-19, which could embrace inhibition of TMPRSS2 and androgen deprivation remedy (ADT).

Benign prostatic hyperplasia

Benign prostatic hyperplasia (BPH), which is outlined as elevated development of epithelial and stromal cells within the prostate gland transition zone, is without doubt one of the most typical circumstances reported in older males. BPH can result in urinary incontinence, urinary retention, in addition to many types of decrease urinary tract signs (LUTS).

The inhibition of the ACE2/Ang(1-7)/Mas pathway resulting from SARS-CoV-2 an infection can worsen BPH. The truth is, a number of earlier research have reported elevated LUTS following COVID-19 in older males.

The worldwide prostate symptom rating (IPSS) that evaluates BPH and LUTS has been reported to be greater for male COVID-19 inpatients as in comparison with their rating earlier than their COVID-19 prognosis.

The category of medicine often known as 5-α reductase inhibitors (5-ARIs), when used alone or together with α1-adrenergic receptor (α1-AR) antagonists, are mostly used within the therapy of BPH. Importantly, 5-ARIs are able to modulating ACE2 ranges and decreasing TMPRSS2 expression, thereby defending sufferers on these medicine in opposition to extreme COVID-19.

Conversely, α1-AR antagonists scale back hyperinflammation and the discharge of cytokines. These brokers have proven to additional scale back mortality charges and hospitalization period amongst  COVID-19 sufferers taking these medicines.

Bladder issues

After the urinary bladder senses that it’s full, it would modulate its nerves and muscle features. An overactive bladder, cystitis, and different bladder dysfunctions led by bladder irritation have been reported to happen following COVID-19.

Male reproductive perform

Secretion of androgens by Leydig cells is vital for spermatogenesis and secondary intercourse character upkeep. Leydig cells have additionally been discovered to manage testicular lymphocyte and macrophage ranges.

Expression of ACE2 receptors has been noticed in Sertoli cells, Leydig cells, and spermatogonia, thus making these testicular tissues potential targets for SARS-CoV-2. Furthermore, COVID-19 in males has been reported to extend serum luteinizing hormone (LH) ranges and reduce the testosterone: LH ratio.

COVID-19 has been reported to induce testicular spermatogenic dysfunction by way of immune or inflammatory reactions. Excessive ranges of proinflammatory cytokines, epididymitis, autoimmune orchitis, in addition to disruption of blood-testis barrier integrity have additionally been noticed resulting from COVID-19. 

COVID-19 can be related to decreased sperm focus, elevated seminal irritation, decreased semen quantity, and elevated seminal apoptotic marker exercise. Sperm DNA fragmentation by SARS-CoV-2 is related to impaired embryo growth, a rise in miscarriage charges, and a decreased implantation charge.

Erectile dysfunction

Erectile dysfunction (ED) in COVID-19 sufferers can come up resulting from altered pulmonary hemodynamics, non-symptomatic hypogonadism, vital psychological burden, and endothelial dysfunction. A number of pre-existing circumstances reminiscent of diabetes, heart problems, weight problems, and hypertension have been reported to extend the severity of COVID-19 and ED.  

Anosmia and ageusia related to COVID-19 also can result in the event of ED. Prevalence of ED has additionally been noticed in healthcare employees who had been at a better danger of affected by COVID-19.

Adverse impacts on the sexual and psychological well being of males also can result in ED. Cytokine storms in some COVID-19 sufferers that subsequently result in vascular endothelial cell apoptosis also can enhance the danger of ED.

Following restoration from COVID-19, ED can be utilized as an indicator of normal well being in males. Phosphodiesterase-5 (PDE5) inhibitors are reported to be efficient within the therapy of COVID-9 and ED.

COVID-19 vaccines

Vaccination in opposition to COVID-19 has been discovered to cut back the variety of COVID-19 circumstances with urological signs. Vaccination may also be useful in prostate most cancers sufferers, as it will probably inhibit the proliferation of most cancers cells. Nevertheless, additional in vivo research are wanted to find out the good thing about COVID-19 vaccines in prostate most cancers sufferers.

Lately, the urological security of the Moderna and Pfizer-BioNTech COVID-19 vaccines has been reported. To this finish, no vital adjustments in sperm parameters have been noticed after the administration of two doses of the Pfizer–BioNTech vaccine.


The present overview determines that greater severity and mortality charges are related to older males affected by COVID-19. COVID-19 adversely impacts the male reproductive perform, thus resulting in impaired fertility and prostate pathologies. Expression of ACE2 and TMPRSS2 may result in an elevated danger of extreme COVID-19 in males.

The acute adjustments within the day by day lives of most males as a result of pandemic have impacted their general psychological and sexual well being, which has mostly led to the event of ED.

Taken collectively, additional analysis is required to make sure urogenital security throughout instances of constantly altering therapies and vaccine protocols.

Journal reference:
  • Kucukyildiz, Okay., Yilmaz-Oral, D., Turkcan, D., et al. (2022). Affect of COVID-19 on male urogenital well being: success of vaccines. Drug Discovery Immediately. doi:10.1016/j.drudis.2022.07.012.



Leave a Reply